Biogen Idec (BIIB) March volatility flat into EPS and outlook
Tweet Send to a Friend
Biogen Idec (Nasdaq: BIIB) is recently down 42c to $53.11. BIIB is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
